This site requires JavaScript to render the code.

Need to know how to enable JavaScript? Go here.

Eurogin QIAGEN symposium

During the QIAGEN symposium at Eurogin the latest clinical performance and study data around Self-screen’s molecular screening and triage solutions were presented by excellent scientists.

Topic 31 May 2021:    Full molecular screening and triage solutions, chaired by Prof. dr. Chris Meijer

Presenters:

Dr. Bart Hesselink (Self-screen B.V., Netherlands) – Clinical performance of the NeuMoDx HPV Test Strip – a detailed overview of clinical requirements of an HPV screening assay and the compliance of the NeuMoDx HPV to the International Guidelines (Meijer criteria)

Dr. David Hawkes (VCS, Australia) – Customer experience NeuMoDx HPV Test Strip – running and operating the NeuMoDx system in daily practice

Dr. Jesper Bonde (Hvidore Hospital, Denmark) – an extensive presentation of QIAsure Methylation Test performance and study data and its advantages as an alternative for cytology based triage strategies .

Topic 2 June 2021:    Evaluation of managing CIN 3+ diagnosed pregnant women by methylation assessment using FAM19A4 / miR124 methylation test

Presenter:

Prof. dr. Monika Hampl  (University Hospital Dusseldorf, Germany)